Literature DB >> 2001369

Carbohydrate structures of recombinant soluble human CD4 expressed in Chinese hamster ovary cells.

M W Spellman1, C K Leonard, L J Basa, I Gelineo, H van Halbeek.   

Abstract

Infection of T-lymphocytes and macrophages by human immunodeficiency virus (HIV) is mediated by the binding of the HIV envelope glycoprotein to the cell-surface receptor glycoprotein CD4. A soluble, recombinant CD4 molecule (rCD4), produced by expression of a truncated CD4 gene in Chinese hamster ovary (CHO) cells [Smith et al. (1987) Science 238, 1704-1707], is in clinical trials as a potential therapeutic agent in the treatment of acquired immunodeficiency syndrome (AIDS). In the present study, the structures of the Asn-linked oligosaccharides of soluble rCD4 have been elucidated. The rCD4 molecule has two potential sites for N-glycosylation, Asn-271 and Asn-300. Tryptic glycopeptides containing either of the sites were purified by reversed-phase HPLC, and their oligosaccharides were released enzymatically. The structures of the oligosaccharides were determined by methylation analysis, high-pH anion-exchange chromatography, fast-atom bombardment mass spectrometry, and 1H NMR spectroscopy at 500 MHz. Asn-271 was found to carry diantennary N-acetyllactosamine-type ("complex") oligosaccharides, of which 8% were asialo, 55% were monosialyl, and 37% were disialyl. Approximately 18% of these structures contained fucose alpha(1-->6) linked to the reducing GlcNAc residue. Two different hybrid structures were found to account for 34% of the oligosaccharides attached to Asn-300. The remainder of the oligosaccharides attached to Asn-300 were diantennary N-acetyllactosamine-type, of which 10% were asialo, 61% were monosialyl, and 29% were disialyl. Approximately 9% of the hybrid structures and 40% of the N-acetyllactosamine structures at Asn-300 were found to contain fucose alpha(1-->6) linked to the innermost GlcNAc residue.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2001369     DOI: 10.1021/bi00223a015

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  An alpha-L-fucosidase from Thermus sp. with unusually broad specificity.

Authors:  E V Eneyskaya; A A Kulminskaya; N Kalkkinen; N E Nifantiev; N P Arbatskii; A I Saenko; O V Chepurnaya; A V Arutyunyan; K A Shabalin; K N Neustroev
Journal:  Glycoconj J       Date:  2001-10       Impact factor: 2.916

2.  Separation and characterization of the two Asn-linked glycosylation sites of chicken serum riboflavin-binding protein. Glycosylation differences despite similarity of primary structure.

Authors:  J S Rohrer; H B White
Journal:  Biochem J       Date:  1992-07-01       Impact factor: 3.857

3.  The growth hormone-encoding gene isolated and characterized from Labeo rohita Hamilton is expressed in CHO cells under the control of constitutive promoters in 'autotransgene' constructs.

Authors:  R Rajesh; K C Majumdar
Journal:  Fish Physiol Biochem       Date:  2008-02-07       Impact factor: 2.794

4.  Interspecies scaling of clearance and volume of distribution data for five therapeutic proteins.

Authors:  J Mordenti; S A Chen; J A Moore; B L Ferraiolo; J D Green
Journal:  Pharm Res       Date:  1991-11       Impact factor: 4.200

5.  Preprotein signature for full susceptibility to the co-translational translocation inhibitor cyclotriazadisulfonamide.

Authors:  Victor Van Puyenbroeck; Eva Pauwels; Becky Provinciael; Thomas W Bell; Dominique Schols; Kai-Uwe Kalies; Enno Hartmann; Kurt Vermeire
Journal:  Traffic       Date:  2019-11-25       Impact factor: 6.215

6.  Quantifying CD4 receptor protein in two human CD4+ lymphocyte preparations for quantitative flow cytometry.

Authors:  Meiyao Wang; Martin Misakian; Hua-Jun He; Peter Bajcsy; Fatima Abbasi; Jeffrey M Davis; Kenneth D Cole; Illarion V Turko; Lili Wang
Journal:  Clin Proteomics       Date:  2014-12-11       Impact factor: 3.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.